Vir Biotechnology Inc

NASDAQ:VIR   3:59:58 PM EDT
43.77
-1.77 (-3.89%)
Products

FDA Says Authorizing Emergency Use Of Sotrovimab For Treatment Of Covid-19

Published: 05/26/2021 22:50 GMT
Vir Biotechnology Inc (VIR) - FDA Says Authorizing Emergency Use of Sotrovimab for Treatment of Covid-19.
FDA Says Authorizing Emergency Use of Sotrovimab for Treatment of Covid-19.
FDA Says Reasonable to Believe Gsk-vir Antibody Sotrovimab May Be Effective for Treatment of Mild-to-moderate Covid-19 in Adults & Pediatric Patients.